What’s Next for 23andMe?
Just over a year ago, 23andMe’s co-founder and CEO Anne Wojcicki was assuring the life sciences industry that the company was a “full-fledged biotech” committed to drug R&D. “We have real labs,” she told PharmaVoice at the time. “Scientists, pipettes. …